I love Essenvia's new AI features, particularly for their efficient ability to construct over 50% of a regulatory submission for multiple countries based on an existing FDA submission. This capability not only streamlines the entire submission process but also ensures accuracy by identifying gaps needed to complete a submission comprehensively. Essenvia's AI impresses me with how it utilizes previous regulatory submissions and interactions with the FDA to draft new submissions that meet previously identified requirements or discrepancies. The AI can effectively discern essential components of a submission based solely on a device's description or overview, saving me significant time and effort. Furthermore, I am impressed by the software's ability to automatically create tables of contents and tables of tables & figures, and even generate a complete eCopy submission immediately after last-minute edits. I also appreciate how user-friendly the setup was, with Essenvia's staff always available to address questions. This responsiveness aids in a smoother transition from manual submission creation, underscoring the efficiency and support quality that Essenvia offers. Review collected by and hosted on G2.com.
One of the eSTARs generated by Essenvia was corrupted, which caused issues during the submission process. Initially, it was accepted by the FDA, but it was not accepted when submitting the response to the AINN. This required me to rebuild the eSTAR manually. Additionally, I feel that the integrated, user-friendly help or tool tips could be improved to assist further with the software usage. Review collected by and hosted on G2.com.
Validated through a business email account
Invitation from a seller or affiliate. This reviewer was not provided any incentive by G2 for completing this review.



